Study on Patient Blood Management in Haematological Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

SUSPENDED

Clinical Phase

NA

Total Enrollment

700 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-08-01

Study Completion Date

2021-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators noticed a variable prescription of blood components to haematological patients in the hospital. This study will analyze the prescription and administration of blood components to Haematological patients (pre measurement). Based on these results guidelines on transfusion triggers will be updated and educated to the physicians and new ICT (information and communications technology) implementations will be added to the electronic order for blood components. The investigators hope to see afterwards (post measurement) a more stable prescription and administration of blood components and a more economic use of blood components.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Patient Blood Management - Use and Outcome

NCT02473666

Hemorrhage

COMPLETED

Continuous Hemoglobin Monitoring: Detection of Acute Blood Loss - Accurate, Timely and Cost-effective

NCT02138175

Bleeding Acute Blood Loss Anemia

WITHDRAWN

Transfusion and Coagulation Management in Trauma Patients After the Introduction of a Coagulation Algorithm

NCT02569606

Hemorrhage

COMPLETED

Longitudinal Cohort of Thrombosis and Hemostasis Diseases

NCT06727669

Immune Thrombocytopenia Thrombotic Thrombocytopenic Purpura Hemophilia A, Acquired +13 more

RECRUITING

Multinational Haemapheresis Vigilance Study

NCT01576237

Blood Donation With Hemapheresis

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is set up as a first step of implementing patient blood management (PBM) in this hospital. PBM is an evidence-based, multidisciplinary approach to optimizing the care of patients who might need transfusion. Not only in pre/per/postoperative setting but also in haematology PBM guidelines can be implemented. Examples are: use of a restrictive haemoglobin trigger for red blood cells (RBC) transfusion, single use policy for the administration of RBC and platelets, administration only for correct indications (including the introduction of an electronic clinical decision support system for ordering blood components), ...

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Blood Transfusion Haematology

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

observational cross-sectional study with pre and post measurement and in between an interventional phase with education, IT implementations etc.

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

all haematologists

There will be only one arm: the haematologists will all be included in the interventional phase.

Interventions are: 1) rewriting guidelines to order blood components; 2) to show the last hemoglobin value on the orders for erytrocytes and the last platelet count on the orders dor thrombocytes and 3)implementation of a clinical decision support system in the electronic rodering of blood components to stimulate restrictive blood transfusion.

Group Type OTHER

education of guidelines

Intervention Type OTHER

* Guidelines will be updated and education will be given to haematologists in several ways.
* ICT implementations: a) last result of haemoglobin and platelet count will be shown on the electronic blood order; b) an electronical clinical decision support system will be implemented to order blood components

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

education of guidelines

* Guidelines will be updated and education will be given to haematologists in several ways.
* ICT implementations: a) last result of haemoglobin and platelet count will be shown on the electronic blood order; b) an electronical clinical decision support system will be implemented to order blood components

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

ICT implementations in the electronic patient file

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all adult patients hospitalised at the haematology wards of the University Hospitals of Leuven (UZ Leuven) between 01/08/2017 and 31/07/2018 (pre measurement) and between between 01/08/2019 and 31/07/2020 (post measurement)

Exclusion Criteria

* ambulatory patients
* patients without blood transfusion administered in their hospitalised period
* patients with no haematological illness that were hospitalised at the haematological wards

Eligible Sex

ALL

Accepts Healthy Volunteers

No